Good News Today — Pancreatic Cancer Breakthrough, FreedomFest & Europe's Clean Energy Bet
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Good News Today — Pancreatic Cancer Breakthrough, FreedomFest & Europe's Clean Energy Bet
-
ナレーター：
-
著者：
(00:01:37) FreedomFest Juneteenth Celebration
(00:02:21) EU Renewable Energy Investment
Today's briefing covers three stories that represent real, measurable progress — in medicine, in community, and in energy.
The headline is daraxonrasib, a new drug targeting the KRAS gene mutation found in over 90% of pancreatic cancers. For decades, this mutation was considered undruggable. Phase three trial results have now changed that. Patients on daraxonrasib survived an average of 13.2 months compared to 6.7 months on standard chemotherapy — nearly double — while also reporting less pain and better quality of life. With a five-year survival rate still sitting around 13%, this is the kind of breakthrough that shifts the entire conversation around one of cancer's hardest fights.
Next, the city of Paducah, Kentucky is celebrating its fifth annual Juneteenth event, now called FreedomFest. Free and open to the public, the celebration marks the 1865 moment when the last enslaved people in the United States learned they were free. Five years of consistent, growing community celebration is how history becomes culture — and Paducah is getting it right.
Finally, the European Investment Bank has signed a €75 million loan with Spanish renewable energy company Ingeteam to fund R&D in clean energy and electrification. The goal: build Europe's own supply chain for wind, solar, and grid technology rather than depending on external sources.
Three stories. Real progress. Worth knowing about.
This episode includes AI-generated content.
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません